EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure

Hyun-Su Lee, Eun-Nam Kim, Gil-Saeng Jeong iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0314054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Hyun-Su Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Daegu Catholic University School of Medicine, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Methamphetamine, CD40 Ligand, T-Lymphocytes. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methamphetamine (METH) is one of the most highly compulsive drugs in the world and has become a major public health problem over the last two decades. Exposure to METH has been investigated to cause neuronal toxicity but little is known about the effect of METH on the activity and toxicity of T lymphocytes. Lupenone has been reported to possess anti-diabetic, anti-inflammatory and anti-apoptotic effects but little is known about whether lupenone has a protective effect on T cell activation in METH-exposed cells. We evaluated the cytotoxicity and cytoprotective effects of lupenone in METH-stimulated Jurkat T cells. Results from the inhibitor assay using CD40L blocking antibodies revealed that this was due to enhanced CD40L expression on the T cells by pre-treatment with lupenone. Pre-treatment with lupenone significantly reduces METH-induced toxicity by restoring the expression of anti-apoptotic proteins in activated T cells. The protective effects of lupenone on activated T cells exposed to METH were associated with the prevention of MAPK and PI3K/Akt/mTOR pathways. These data suggest lupenone protected T cell activity by elevating CD40L expression and cell viability in cells exposed to methamphetamine. Our data showed that lupenone treatment recovered the expression of IL-2 and CD69 in METH-exposed cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethamphetamineCD40 LigandT-LymphocytesHumansJurkat CellsCell SurvivalLymphocyte ActivationSignal TransductionPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesApoptosisAntigens, CDAntigens, Differentiation, T-LymphocyteInterleukin-2Lectins, C-TypeCD69 Antigens

Substanzen

MethamphetamineCD40 LigandPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAntigens, CDAntigens, Differentiation, T-LymphocyteInterleukin-2Lectins, C-TypeCD69 Antigens

Autor:innen und Institutionen

  • Department of Physiology, Daegu Catholic University School of Medicine, Daegu, Republic of Korea.
  • College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.

ORCID-Profile: Gil-Saeng Jeong

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, H. S., Kim, E. N., & Jeong, G. S. (2025). Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure. PLOS ONE. https://doi.org/10.1371/journal.pone.0314054

Vancouver

Lee HS, Kim EN, Jeong GS. Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure. PLOS ONE. 2025. doi:10.1371/journal.pone.0314054

BibTeX
@article{Lee2025,
  author = {Lee, Hyun-Su and Kim, Eun-Nam and Jeong, Gil-Saeng},
  title = {Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0314054}
}
Kostenlos starten →